- There are over one million infected with Coronavirus around the globe.
- The race to find a vaccine is on.
- A new technology allows rapid testing of indoors air space for such viruses.
There is a race around the world to create a successful vaccine against coronavirus and repurposing existing classes of drugs to use for coronavirus treatment. According to the John Hopkins live tracker the number of infected around the globe crested over one million, with rover 50,000 reported dead. How many cases were concealed by China remains unanswered.
In the US alone there are over 243,000 cases, with more than 5,900 deaths. The quarantines continue to be extended by a myriad of nations. Toronto, Canada cancelled all events until June 30th. In Russia, President Vladimir Putin extended time off work from a week to the whole month of April.
There is a push for the broader use of masks in public. Due to shortages, there are many videos showing how to make your own mask. Also, US President Donald Trump suggested it is possible to substitute masks for scarves, as it is more important to leave the supply of masks for the front line health care workers.
Additionally, now there is a test that can let you know if you are immune to coronavirus. The cost is around $42.
COVID-19 has raised the issue of the need to develop a method for rapid analysis of indoor air that can detect biopathogens: pathogenic bacteria, viruses, etc. One of these technologies has been patented by Russian doctors.
The technology described as a “method of multiplex immunological analysis of biological samples from the air in automatic mode” consists of several key stages.
Method of multiplex immunological analysis of biological samples from the air in automatic mode, including a number of consecutive stages:
- The device collects air particles (bioaerosol), converts them to a liquid state, automatically prepares samples for analysis, and then analyzes the sample on a multiplex immunological analyzer.
- The immunological analysis reactor is made in the form of a container made of a chemically resistant material with a volume of 1.5 ml, in which the temperature is maintained at 37 °C.
- Air samples are analyzed using special fluorescent tags that are read from the samples using a laser.
In some types of analysis, special detection antibodies can be used. Details of the technology are provided in the published patent which is held by the Russian Ministry of Health.
The technology patented by Russian doctors allows for automatic continuous multiplex immunological analysis of air for the presence of biopathogens in it, which means that rapid measures can be taken to protect humans or animals from the harmful effects of bacteria, viruses, toxins, genetic vectors, and even nanoparticles. Its advantage over analogues is the developed automatic system of samples for immunological analysis.
The new technology disclosed in the patent significantly reduces the time of sample investigation, provides continuous monitoring of the air composition, primarily in medical institutions, and also increases the accuracy of determining biopathogens (including coronavirus) in the air by an order of magnitude.